Why Is Big Tech Buying Healthcare Companies? It’s the Data and Market, Stupid
Of late, tech companies have been quite interested in healthcare companies. Why are tech companies buying healthcare companies?
Healthcare
The latest news in the healthcare sector including biotech and telehealth.
Certain States Criminalize Abortions — And Impose Harsh Punishments
Several states have abortion bans in place that ultimately make the procedure illegal and worthy of criminal punishments. In some states, getting an abortion will lead to being arrested.
HSA Accounts Help Combat Inflation Due to Tax Benefits
A health savings account (HSA) could help you combat inflation thanks to its tax benefits. Here's what we know about an HSA account as a hedge against inflation.
When Will the Pfizer Lyme Disease Vaccine Be Here and Will It Work?
The world has a promising Lyme disease vaccine candidate courtesy of Pfizer Inc. (PFE) and its partner in the process, Valneva SE (VALN).
Pfizer to Acquire Global Blood Therapeutics, Achieves Long-Time Goal
Pfizer is acquiring Global Blood Therapeutics in a deal valued at $5.4 billion, which helps Pfizer realize its long-time goal of having a sickle-cell disease portfolio.
CVS Wants to Acquire Signify—The Potential Deal, Explained
CVS reportedly has plans to put in a bid to acquire Signify Health. What are the expected terms of the deal, and will it go through?
States Expand Access to Monkeypox Vaccines — Who’s Eligible Amid Short Supply?
Most states are only providing the monkeypox vaccine to certain populations since it's in short supply. Find out who is eligible for the monkeypox vaccine.
Hydrocodone, the Most Prescribed Opioid in the U.S., Might Face a Shortage
The healthcare industry might be facing a new shortage — this time, hydrocodone. Here's what we know about the drug and its availability.
Is the Cassava Sciences Lawsuit Legit or a Product of Short-Selling?
As Cassava Sciences endures class action lawsuits, questions remain: Are the investigations legitimate or a product of short-seller gamification?
SIGA Technologies Stock: Lots of Potential on WHO Monkeypox Declaration
Now that WHO has declared monkeypox a global health emergency, what's SIGA Technologies stock's forecast?
A Case of Polio Emerged in New York — Are Vaccines Readily Available?
Polio vaccines still exist and are included in the CDC’s standard child immunization schedule. With a case recently emerging in New York, health officials urge the unvaccinated to get vaccinated.
One Medical Stock Skyrockets 70% After Amazon Buyout
Amazon announced its $3.9 billion acquisition of primary health care company One Medical on Thursday. Why did Amazon buy One Medical?
Why Medicare Advantage Plans Might Not be As Good As They Sound
Medicare Advantage plans seem to offer numerous benefits but are looked down upon for many reasons. Are they good or bad?
Why Boycott Walgreens? Birth Control, Baby Formula Controversy
Consumers are fed up with Walgreens over reported controversy surrounding birth control and baby formula. As a result, boycotts are ensuing.
Supply Chain Disruptions Have Led to an Epidural Shortage
Supply chain disruptions have caused a shortage in IV contrast, epidural medication, and catheters, which could impact the availability of epidural infusions.
Is the Newly Approved Novavax COVID-19 Vaccine Better Than Moderna?
The FDA has approved the Novavax COVID-19 vaccine for emergency use. Here’s the Novavax vaccine compares to Moderna — and how to get it.
HRA Pharma Doesn’t Have Stock: How to Invest in Opill Maker
HRA Pharma has filed with the FDA for the first-ever OTC birth control pill in the country. Does HRA Pharma have stock and can you invest in the company?
California to Manufacture Insulin, But Availability Date Remains Unclear
California Gov. Gavin Newsom says the state will begin manufacturing insulin to offer a more affordable option for diabetes patients.
FDA Authorizes Pharmacists to Prescribe Pfizer’s Paxlovid
The FDA has revised its emergency use authorization for Paxlovid. Can pharmacists prescribe the COVID-19 drug now?
The Company Behind Myrkl, the World’s First Hangover Pill
Researchers claim to have created a hangover-curing pill, which they've named Myrkl. Here’s the company behind it and who’s investing.
How Much Is Urgent Care Without Insurance? Costs Compared
How much is urgent care without insurance? See how out-of-pocket costs for urgent care vary by location, and find out when to visit an ER instead.
Does Plan B Owner Foundation Consumer Healthcare Have Stock?
Plan B is owned by Foundation Consumer Healthcare. Does the company have stock and is it publicly traded? Here are all the details for investors.
Some Drug Stores Are Capping Plan B Purchases — There Isn't a Shortage
CVS drug stores are capping Plan B purchases, but it isn't necessarily because of a shortage. Why are purchases being capped? Here's what to expect.
Plan B Pill Demand Surges on Overturning of Roe v. Wade
Since Roe v. Wade's overturn, people are turning to emergency contraceptive pills, or "Plan B." Which company owns the Plan B pill?
Abortion Pill Maker Danco Laboratories Doesn’t Look Set to IPO Soon
Danco Laboratories, which manufactures abortion pill Mifeprex, is seeing interest from investors. Is its stock publicly traded?
FDA Bans All Juul Products Currently Being Sold and Distributed in the U.S.
After a $40 million lawsuit settlement, Juul is facing trouble again. This time, the company's e-cigarettes have been completely banned by the FDA.
What’s Behind the FDA's Ban on Juul E-Cigarettes
E-cigarette maker Juul's appeal to the FDA to allow sales of its tobacco-flavored products in the U.S. may be rejected. Why is Juul getting banned?
The Tampon Shortage Is Widespread, and There’s No End in Sight
Tampons are the latest addition to the U.S. shortage list. How long will the tampon shortage last?
Latest Updates in the Roundup Cancer Case, Explained
In the latest update on the Roundup cancer case, owner Bayer hoped thousands of cases would get dismissed. The court upheld the finding that Roundup caused cancer.
Staffing Shortages Reach Nursing Homes — Serious Issue Isn't New
The nursing home industry is now getting hit by another wave of staffing shortages. Here's why the staffing shortages are dangerous for residents.
Explainer: Pfizer vs. Moderna COVID-19 Vaccines for Kids Under 5
Pfizer and Moderna both offer a COVID-19 vaccine for kids under five. Now, the FDA has approved both vaccines for children over six months of age.
How Severe Is the Insulin Shortage in the U.S.?
Supply-chain issues are impacting everything from food to clothes, and even important drugs. Is there an insulin shortage in the U.S.?
Forecast for Eli Lilly Stock as FDA Approves Alopecia Drug
Eli Lilly and Co. stock is on the move. What’s the forecast for LLY stock as the FDA approves its alopecia drug? Here's what investors can expect.
Weight-Loss Wonder Wegovy Might Be Available in the Second Half of 2022
Wegovy is Novo Nordisk’s blockbuster drug for weight loss. Why's there a Wegovy shortage?
Women Can Earn Substantial Money Through Egg Donation or Surrogacy
Egg donation and surrogacy are often advertised as having high compensation for very little effort, but they're significant commitments and not an easy way to make money.
Biotech Company Novavax Has a Promising COVID-19 Vaccine
Novavax has a new COVID-19 vaccine available and it has already shown some promise. Where is Novavax made and when will it be available to the public?
Omicron Booster Will Likely Be Available Late Summer 2022
Moderna announced strong results for its vaccine against the omicron variant of the COVID-19 virus on June 8. When will omicron booster be available?
Tirzepatide Could Be a Big Weight-Loss Winner for Eli Lilly
Tirzepatide has recently shown great potential in weight loss trials. Who makes tirzepatide?
How To Invest in Dostarlimab, the Cancer Drug With “Unheard-Of” Results
In a study, all cancer patients who were treated with dostarlimab went into remission. How can you invest in dostarlimab?
Walmart and CVS Will Stop Filling Certain Controlled Substance Prescriptions
CVS and Walmart have decided to longer fill prescriptions for controlled substances issued by Cerebral and Done. We'll see why and what it means for some customers.
Conspiracy Theories Brew As World Health Organization Considers a Pandemic Treaty
The World Health Organization is talking about creating a treaty for future pandemics. Here's the pandemic treaty, explained.
5 Healthcare Stocks With 1,000 Percent or More Upside Potential
You can buy healthcare stocks with 1,000 percent upside potential for under $1. What are the top healthcare stocks with 1,000 percent or more upside potential?
Senator Rick Scott's Past Medicare Fraud Case Raises Flags Years Later
A look into Senator Rick Scott's Medicare fraud and why its still haunting him amid his plans for Social Security and Medicare.
You Can Still Get Free COVID-19 Tests — Here’s How
About two and a half years into the COVID-19 pandemic, you can still get tested for free in the U.S. Here are your options. The government is giving out more free tests.
COVID-19 Detected in North Korea — Is It Really the First Case?
North Korea recently acknowledged that it has detected its first-ever outbreak of the COVID-19 virus. How did the country remain COVID free for so long?
Investments in Mental Health Companies Grow, Industry Stocks to Follow Suit
Investors are becoming more interested in mental health companies. Here are mental health stocks to consider for your portfolio as the segment materializes.
CVS Is Closing Some Stores Amid Market and Industry Changes
Some CVS stores are closing across the U.S. and customers are being directed to alternative outlets. What stores are closing and why is the company making changes?
Hospitals Expect an IV Contrast Shortage, Limited Diagnostic Imaging
Due to COVID-19 lockdowns in Shanghai, many hospitals are anticipating an IV contrast shortage, which will mean rationing the supply for diagnostic imaging.
The Best Generic Pharmaceutical Stocks for Long-Term Investing
The generic medication market can be lucrative. What are the best generic drug stocks to buy for long-term investing?
Biogen CEO Michel Vounatsos Is Stepping Down, Company Look to the Future
On May 3, Biogen announced that CEO Michel Vounatsos is stepping down from his role. His net worth is estimated to be over $32 million.